PT
Preferred
Pliant Therapeutics
South San Francisco,
CA,
United States
(remote)
19 days ago
M
Merck
Rahway,
NJ,
United States
(on-site)
18 hours ago
M
Merk
Rahway,
NJ,
United States
(on-site)
18 hours ago
M
Merck
North Wales,
PA,
United States
(on-site)
18 hours ago
M
M
M
Merck
Rahway,
NJ,
United States
(on-site)
18 hours ago
M
M
Merck
West Point,
PA,
United States
(on-site)
18 hours ago
M
Merck
Boston,
MA,
United States
(on-site)
18 hours ago
M
Merck
Rahway,
NJ,
United States
(on-site)
18 hours ago
M
Merck
Rahway,
NJ,
United States
(on-site)
18 hours ago
M
Merck
Cambridge,
MA,
United States
(on-site)
18 hours ago
M
Merck
Philadelphia,
PA,
United States
(on-site)
18 hours ago
M
M
Merck
North Wales,
PA,
United States
(on-site)
18 hours ago
M
Merck
North Wales,
PA,
United States
(on-site)
18 hours ago
U
University of VA
Charlottesville,
VA,
United States
(on-site)
1 day ago
U
U
University of Virginia
VA,
United States
(on-site)
1 day ago
U
University of Virginia
VA,
United States
(on-site)
1 day ago
M
Merck
Scranton,
PA,
United States
(on-site)
2 days ago
M
M
Merck
Rahway,
NJ,
United States
(on-site)
2 days ago
M
Spotlight
Preferred
Pliant Therapeutics
South San Francisco, California, United States
(remote)
19 days ago
Description
Company Overview
Pliant Therapeutics is a public, clinical stage biopharmaceutical company focused on the discovery and development of novel therapies for fibrotic diseases. Founded by Third Rock Ventures with world-renowned academic thought leaders, Pliant is raising the bar to meet the unmet medical needs of physicians, patients and families impacted by fibrotic disease. The Company’s focus is on mechanism-based intervention in the fibrotic process using small molecules.
The Company’s lead product candidate, PLN-74809, is an oral, small molecule selective inhibitor of the αvβ1 and αvβ6 integrins that play a key role in multiple fibrotic pathways. PLN-74809 has received Orphan Drug Designation from the U.S. Food and Drug Administration in both idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC) and are currently in Phase 2a clinical trials for these indications. The company recently reported positive data from its Phase 2a trial in IPF and is currently ramping up activities in preparation for a late-stage clinical trial at worldwide sites.
Pliant has also developed PLN-1474, a small molecule, selective inhibitor of αvß1 for the treatment of nonalcoholic steatohepatitis, or NASH with liver fibrosis. Pliant is initiating a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. The Company also has discovery and development programs in oncology and muscular dystrophies.
The Company is seeking passionate, creative, and dedicated individuals to join our team and contribute to our mission.
Description
The Senior Clinical Site Liaison is a critical position within Pliant’s Development Operations team and will be responsible for co-developing, managing and implementing strategic plans to provide non-promotional clinical, educational, and study support across Pliant’s Development portfolio. The Senior Clinical Site Liaison reports to the Head of Clinical Site Liaisons.
Responsibilities
- Serve as a CSL therapeutic team lead, co-developing, managing, and implementing strategic plans to build a well-informed and motivated clinical site base for Pliant’s clinical development portfolio
- Develop clinical site engagement communications and presentations for site initiation, office visits, investigator meetings, advisory boards to enhance current and future clinical trial awareness
- Serve as CSL for sites with PIs who are key opinion leaders, Pliant advisory board, or strategic planning committee members
- Identify and communicate key clinical trial issues and insights to the Head of Clinical Site Liaisons and Clinical Operations Study leads, and any other appropriate functional stakeholders to help influence clinical trial execution including, but not limited to, site identification, site start-up, patient screening and accrual, and patient retention
- Collaborate with Development Operations, Clinical Development, and external stakeholders to support clinical needs and monitor study performance and progress
- Facilitate identification of clinical trial site and community educational needs for Pliant clinical trials
- Attends scientific and professional conferences
- Participate in Pliant community outreach and engagement activities
- Maintain business and clinical knowledge of the treatment landscape including current treatment strategies, current and pending competitors, and new therapeutic developments
- Maintain awareness of internal scientific publication strategies to understand impact on business and clinical development
- Adhere to regulatory and compliance guidelines and company policies
Requirements
Qualifications
To perform this job successfully, an individual must be able to perform each essential duty. The requirements listed below are representative of the knowledge, skill, abilities and prior experience required.
- Advanced degree (MS/DO/MD/PhD/PharmD) with at least 6 years clinical trial experience including leadership roles
- Previous experience in a CSL, MSL, or similar role preferred
- Ability to travel domestically and internationally up to 50%, including travel to Pliant at least 6 times/year
- Working knowledge of protocol and clinical drug development processes, clinical study design, study planning and management, and monitoring
- Strong communication, interpersonal, and relationship management skills
- High attention to detail
- Ability to set priorities and juggle multiple demands
- Ability to think critically and be a proactive problem-solver
- Ability to work independently while exercising initiative, flexibility, and sound judgment
- Comfortable working with different levels of the company including senior level management
- Demonstrated proficiency in Microsoft Word, PowerPoint, and Excel
- Ability to operate in alignment with Pliant’s values
Position location
- Remote, field-based, with travel to Pliant at least 6 times per year.
Pliant requires all new hires to be fully vaccinated prior to the first date of employment (subject to any legally required exemptions).
The annual base salary for this role is $170,000 – $182,000. Individual pay may vary based on additional factors, including, and without limitation job-related skills, experience, work location and relevant education or training. Pliant’s compensation package also includes benefits, equity, and annual target bonus for fulltime positions.
Job Information
- Job ID: 69240073
- Workplace Type: Remote
- Location:
South San Francisco, California, United States - Position Title: Senior Clinical Site Liaison
- Company Name For Job: Pliant Therapeutics
- Job Function: Project Leader
- Job Type: Full-Time
- Required Travel: 50-75%
- Salary: $170,000.00 - $182,000.00 (Yearly Salary)
M
Sr. Clinical Research Associate (Northern...
Merck
San Francisco,
CA,
United States
(on-site)
M
Sr. Clinical Research Associate (Northern...
Merck
Palo Alto,
CA,
United States
(on-site)
M
Sr. Clinical Research Associate (Northern...
Merck
Oakland,
CA,
United States
(on-site)
M
Senior Medical Writer - Oncology
Merck
South San Francisco,
CA,
United States
(on-site)